AGP Executive Report
Last update: 11 hours agoMedicinal Cannabis Deal: Dutch pioneer Bedrocan and Berlin extractor Becanex are launching a strategic product cooperation in Germany, building on a research link that started back in 2014. Vaccine R&D Funding: Intravacc says it has secured French approval under the Crédit d’Impôt Recherche (CIR) for vaccine R&D and cGMP manufacturing services for 2025–2027. Investor Spotlight: argenx management will present at major June investor conferences, with a live webcast planned for early June. Public Health Watch: A cruise ship tied to a deadly hantavirus outbreak (MV Hondius) is getting extra cleaning in Rotterdam before it can leave, after GGD advised additional measures; WHO says the situation is stable for now, with quarantined passengers and crew still under monitoring. Food & Safety: Walmart issued an urgent recall of a popular seasoning over potentially fatal health risk. Policy & Access: A Canadian think-tank argues universal health systems should use cost-sharing to reduce unnecessary visits—an idea that directly clashes with patient advocates.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.